SCHEMBL278967

SCHEMBL278967

C=C(/N=C/c1cc(F)ccc1Oc1ccc(C#N)cc1)O[Si](C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXA2R P21731 3/20 0.38
SCN9A Q15858 5/20 0.38
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
SLC22A12 Q96S37 1/20 0.35
AR P10275 1/20 0.34
SLC6A4 P31645 1/20 0.33
SCN8A Q9UQD0 1/20 0.33
SCN10A Q9Y5Y9 1/20 0.33
ICAM1 P05362 2/20 0.33
SELE P16581 2/20 0.33
VCAM1 P19320 2/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
CYP11B1 P15538 1/20 0.32
CCNC P24863 1/20 0.32
CDK8 P49336 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL275612 1.00 TBXA2R (0.38) TBXA2RSCN9AALDH1A1LMNAL3MBTL1
SCHEMBL279179 0.90 LMNA (0.44) SCN9AALDH1A1LMNAL3MBTL1SLC6A4
SCHEMBL275677 0.90 LMNA (0.44) SCN9AALDH1A1LMNAL3MBTL1SLC6A4
SCHEMBL279205 0.87 TBXA2R (0.36) TBXA2RSCN9AARSLC6A4ICAM1
SCHEMBL279350 0.87 TBXA2R (0.36) TBXA2RARSLC6A4CYP11B1
SCHEMBL279191 0.87 LMNA (0.43) ALDH1A1LMNAL3MBTL1SCN8ASCN10A
SCHEMBL274647 0.87 LMNA (0.43) ALDH1A1LMNAL3MBTL1SCN8ASCN10A
SCHEMBL279339 0.81 LMNA (0.40) ALDH1A1LMNAL3MBTL1
SCHEMBL279428 0.81 MAPT (0.38) L3MBTL1SLC6A4
SCHEMBL275415 0.81 MAPT (0.38) L3MBTL1SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8134001-B2 Spiroindolinone derivatives HOFFMANN-LA ROCHE INC. (US) 2012-03-13 US disclosed
US-20090156610-A1 Spiroindolinone Derivatives DING QINGJIE 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156610-A1 Spiroindolinone Derivatives SDHA, AR, XPOT TBXA2R 236/4885SCN9A 1484/4885ALDH1A1 138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.